Press Release Archive
-
FDA Clears First Blood Glucose Monitoring System To Automatically Send Results Wirelessly Via Bluetooth® Technology to iOS DevicesOneTouch® Verio®Sync Meter With Mobile App Allows Patients To Easily View and Share Blood Sugar Information Using Their iPhone®, iPad® or iPod touch®
-
“Healthy Vision™ With Dr. Val Jones” Show Now Available On All About Vision®
-
Johnson & Johnson Comments on Venezuelan Currency Devaluation
-
Janssen Files First Regulatory Application for Simeprevir (TMC435) for the Treatment of Genotype 1 Hepatitis C Patients in Japan
-
Johnson & Johnson to Participate in 2013 Citi Global Health Care Conference
-
New Prom Grooming Guides For Girls And Guys Now Available From ACUVUE® Brand Contact LensesGuides Offer Helpful Advice on a Variety of Personal Care Topics to Help Teens Prepare for Prom
-
Janssen Healthcare Innovation launches inaugural Innovation Challenge Prize for Dementia in collaboration with the NHS
-
Ibrutinib Receives Two Oncology Breakthrough Therapy Designations from U.S. Food and Drug AdministrationInvestigational oncology agent for B-cell malignancies jointly being developed by Janssen and Pharmacyclics
-
Follow-up Data Show ZYTIGA® Plus Prednisone Continues to Delay Progression of Metastatic Castration-Resistant Prostate Cancer in Patients without Prior Chemotherapy
-
Johnson & Johnson to Participate in 2013 Leerink Swann Global Health Care Conference